Who should be really considered as a poor mobilizer in the plerixafor era?

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Thierry Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine · 1995 · 2.4K citations

Medicine, Hematology, Oncology +14

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

J. A. Child, Gareth J. Morgan, Faith E. Davies et al. · New England Journal of Medicine · 2003 · 1.8K citations · Full text

Medicine, Hematology, Oncology +17

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

AlessandroM. Gianni, Marco Bregni, A. Stern et al. · The Lancet · 1989 · 752 citations

Life Sciences, Hematology, Immunology +10

High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

Harry C. Schouten, Wendi Qian, Stein Kvaløy et al. · Journal of Clinical Oncology · 2003 · 479 citations

Medicine, Hematology, Oncology +15

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Jean‐Paul Fermand, Sandrine Katsahian, Marine Diviné et al. · Journal of Clinical Oncology · 2005 · 401 citations · Full text

Medicine, Hematology, Oncology +17